ReMed 2019 Urgences ReMed Magazine Numéro 7-8 (6) | Page 25

Brain on Fire: Anti-NMDA Receptors Encephalitis ASMA AIT SAID The Central Nervous System(CNS) is the ultimate priority of the immune system when the human body is being invaded by any given pathogen.The blood-brain barrier is an actual shield preventing any potentially harmful microorganism from attending the CNS ensuring thus the safety of neurones and their functions.However, many types of microorganisms, namely viruses (Herpes simplex virus for instance) are able to cross this strong wall and reach the human brain resulting in an inflammation of the brain parenchyma associated with neurological dysfunction causing viral, bacterial or even fungi encephalitis. Nonetheless, Encephalitis can also be induced by an auto-immune disorder and the most common one is called anti-NMDA Receptors encephalitis which has been recently discovered. This illness can be very dangerous and life threatening. Hence, early diagnosis and treatment are fundamental. In view of the possibility of misdiagnosing it as a primary psychiatric disorder -namely schizophrenia- this article aims to highlight the principal mechanisms of this auto-immune disease, the different phases through which patients go, the key to a firm diagnosis and the proper treatment. Introduction: T he etiology of encephalitis is primarily sus- pected to be viral. However, viral-linked inves- tigations frequently failed to identify a specific pathogen. This has led health professionals to make further research to discover other likely causes among which auto-immune disorders were detected. Anti-NMDA receptors encephalitis is an autoimmune disorder in which the immune system produces anti-bodies against specific receptors called NMDA (N-Methyl-D-Aspartate); generating an inflammatory process in the brain parenchyma. These receptors are highly expressed in the limbic system (hippocampus, amygdala, hypothalamus, cingulate gyrus and limbic cortex) as well as other parts of the CNS. They play a critical role in synaptic transmission and plasticity contributing to the control of thoughts, attitude, emotions and movements. The antibodies addressed against them engender continued deterioration of these functions. This disease can arise in children as well as young adults. Both male and female with a higher female prevalence. Symptoms include prominent psychiatric signs along with a highly characteristic set of neurological deficits, cognitive and behavioural manifestations. Since the emergence of anti-NMDA-R encephalitis in 2007, neurologists and other specialists recognize it to be a considerable differential diagnosis for viral encephalitis, on the one hand (especially herpetic encephalitis) and for psychotic conditions in their early phase on the other hand; especially schizophrenia which is marked by similar symptoms to those of the early stage of anti-NMDAR encephalitis. What are NMDA receptors? (4,5,10) NMDAR, along with AMPA and Kainate receptors, are a sub-type of ionotropic Glutamate receptors, a category of ligand-gated channels that bind the major excitatory transmitter in the brain and spinal cord, in order to open: Amino acid L-Glutamate. NMDA receptors are made of two sub-units: NR1 and NR2. Each binding a specific substance: the former binds to Glutamate and the latter to Glycine. NR1 was proved to be the main target of the produced anti- bodies (4). These receptors are typically clustered at post- synaptic sites in the membrane, taking a great part of excitatory synapses of the mature nervous system. NMDA receptors have many interesting features. They are permeable to Ca2+ ions,as well as to Na+ and K+ ions. Their opening depends on both membrane voltage as well as the nature of the neuro-transmitter. The binding of glutamate to the NR2 subunit depends on the concentration of the glycine in extra cellular space which is quite effective under normal conditions. The ionic current is controlled by extra cellular Mg2+. In fact, at resting membrane potentials, Mg2+ binds to a specific site of the ligand-binding channels, ReMed Magazine - Numéro 7/8 25